Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)
China
· Delayed Price · Currency is CNY 4.610
-0.050 (-1.07%)
Mar 11, 2026, 3:00 PM CST
SHA:603669 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | -118.38 | -130.76 | -151.5 | -195.86 | 65.9 | 160.07 | Upgrade
|
| Depreciation & Amortization | 31.19 | 31.19 | 46.31 | 45.32 | 43.1 | 37.56 | Upgrade
|
| Other Amortization | 8.63 | 8.63 | 3.7 | 4.63 | 5.61 | 8.1 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.08 | -0.08 | -0.08 | -0.45 | 0.01 | 0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | 32.39 | 32.39 | 8.39 | 9.01 | 1.76 | 6.46 | Upgrade
|
| Loss (Gain) From Sale of Investments | 14.59 | 14.59 | 14.53 | 8.12 | -16.86 | -0.49 | Upgrade
|
| Provision & Write-off of Bad Debts | 18.77 | 18.77 | 10.05 | 6.94 | 0.27 | 0.39 | Upgrade
|
| Other Operating Activities | -71.31 | -4.93 | 3.71 | 5.69 | 17.81 | 12.65 | Upgrade
|
| Change in Accounts Receivable | -201.43 | -201.43 | 4.81 | 46.64 | 42.65 | 62.65 | Upgrade
|
| Change in Inventory | 26.26 | 26.26 | -17.34 | 1.55 | 15.83 | 19.94 | Upgrade
|
| Change in Accounts Payable | 92.93 | 92.93 | 39.85 | -4.71 | -45.06 | -177.9 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | - | - | -1.68 | Upgrade
|
| Operating Cash Flow | -164.88 | -110.89 | -37.87 | -66.36 | 128.5 | 126.81 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | 1.33% | -46.17% | Upgrade
|
| Capital Expenditures | -0.97 | -8.85 | -23.13 | -42.84 | -54.82 | -61.95 | Upgrade
|
| Sale of Property, Plant & Equipment | 9.61 | 2.07 | 0.18 | 2.62 | 0.01 | 0.07 | Upgrade
|
| Investment in Securities | 369.16 | 359.47 | -44.56 | 159.33 | -396.76 | 165 | Upgrade
|
| Other Investing Activities | -160.55 | 13.1 | 15.61 | 12.43 | 18.72 | 24.72 | Upgrade
|
| Investing Cash Flow | 217.25 | 365.79 | -51.9 | 131.54 | -432.85 | 127.85 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 205.11 | 480 | - | Upgrade
|
| Long-Term Debt Issued | - | - | 117.35 | - | 6.7 | 1,007 | Upgrade
|
| Total Debt Issued | 5 | - | 117.35 | 205.11 | 486.7 | 1,007 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -545 | -599.57 | - | Upgrade
|
| Long-Term Debt Repaid | - | -324.73 | -208.44 | -2.29 | -4.28 | -75 | Upgrade
|
| Total Debt Repaid | -207.38 | -324.73 | -208.44 | -547.29 | -603.85 | -75 | Upgrade
|
| Net Debt Issued (Repaid) | -202.38 | -324.73 | -91.09 | -342.18 | -117.14 | 932.46 | Upgrade
|
| Repurchase of Common Stock | -1.65 | -1.65 | -52.11 | -56.26 | - | - | Upgrade
|
| Common Dividends Paid | -5.53 | -5.73 | -8.08 | -80.13 | -159.21 | -112.99 | Upgrade
|
| Other Financing Activities | 208.78 | 10.04 | -7.71 | 5.23 | -2.54 | -7.55 | Upgrade
|
| Financing Cash Flow | -0.78 | -322.08 | -158.99 | -473.35 | -278.89 | 811.92 | Upgrade
|
| Net Cash Flow | 51.58 | -67.18 | -248.76 | -408.16 | -583.24 | 1,067 | Upgrade
|
| Free Cash Flow | -165.85 | -119.74 | -61.01 | -109.2 | 73.69 | 64.86 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 13.60% | -71.14% | Upgrade
|
| Free Cash Flow Margin | -38.52% | -31.53% | -30.99% | -37.75% | 9.95% | 6.48% | Upgrade
|
| Free Cash Flow Per Share | -0.23 | -0.17 | -0.09 | -0.15 | 0.10 | 0.09 | Upgrade
|
| Cash Income Tax Paid | 15.72 | 7.92 | 13.43 | 21.39 | 82.51 | 130.78 | Upgrade
|
| Levered Free Cash Flow | -155.56 | -113.77 | -35.79 | -56 | -163.69 | 109.48 | Upgrade
|
| Unlevered Free Cash Flow | -132.87 | -96.66 | -33.48 | -52.35 | -154 | 116.51 | Upgrade
|
| Change in Working Capital | -80.68 | -80.68 | 27.01 | 50.25 | 10.9 | -97.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.